Beaurang Pierre
Insider CIK 1817226 · NRIX Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-08-10 | 2021-08-11 | 7,500 | — | $0 | 6,562 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-08-10 | 2021-08-11 | 5,620 | $29.74 | $167.1K | 6,210 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-08-10 | 2021-08-11 | 1,880 | $30.21 | $56.8K | 4,330 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-08-10 | 2021-08-11 | 7,500 | $1.11 | $8.3K | 11,830 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-07-12 | 2021-07-12 | 7,500 | — | $0 | 14,062 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-07-12 | 2021-07-12 | 7,100 | $23.88 | $169.5K | 4,730 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-07-12 | 2021-07-12 | 7,500 | $1.11 | $8.3K | 11,830 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-07-12 | 2021-07-12 | 400 | $24.73 | $9.9K | 4,330 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-06-10 | 2021-06-11 | 7,500 | — | $0 | 21,562 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 400 | $30.90 | $12.4K | 4,330 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 1,100 | $30.01 | $33.0K | 4,730 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 6,000 | $29.15 | $174.9K | 5,830 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-06-10 | 2021-06-11 | 7,500 | $1.11 | $8.3K | 11,830 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-05-10 | 2021-05-11 | 7,500 | — | $0 | 29,062 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-05-10 | 2021-05-11 | 4,299 | $26.07 | $112.1K | 7,531 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-05-10 | 2021-05-11 | 2,501 | $26.87 | $67.2K | 5,030 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-05-10 | 2021-05-11 | 700 | $27.66 | $19.4K | 4,330 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-05-10 | 2021-05-11 | 7,500 | $1.11 | $8.3K | 11,830 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-04-12 | 2021-04-13 | 2,396 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-04-12 | 2021-04-13 | 5,104 | — | $0 | 36,562 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 4,072 | $26.83 | $109.3K | 7,758 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 2,883 | $27.67 | $79.8K | 4,875 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 545 | $28.65 | $15.6K | 4,330 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-04-12 | 2021-04-13 | 5,104 | $1.11 | $5.7K | 11,830 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-04-12 | 2021-04-13 | 2,396 | $0.84 | $2.0K | 6,726 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-03-25 | 2021-03-25 | 4,330 | — | $0 | 2,396 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-03-25 | 2021-03-25 | 4,330 | $0.84 | $3.6K | 4,330 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-03-08 | 2021-03-09 | 7,500 | — | $0 | 6,726 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-03-08 | 2021-03-09 | 200 | $38.34 | $7.7K | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-03-08 | 2021-03-09 | 4,490 | $37.31 | $167.5K | 200 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-03-08 | 2021-03-09 | 2,810 | $36.48 | $102.5K | 4,690 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-03-08 | 2021-03-09 | 7,500 | $0.84 | $6.3K | 7,500 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-02-18 | 2021-02-22 | 9,107 | — | $0 | 14,226 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-02-18 | 2021-02-22 | 2,096 | — | $0 | 14,678 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise deriv | 2021-02-18 | 2021-02-22 | 3,797 | — | $0 | 72,869 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-02-18 | 2021-02-22 | 9,107 | $0.84 | $7.6K | 9,107 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-02-18 | 2021-02-22 | 3,797 | $7.26 | $27.6K | 12,904 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | M Exercise | 2021-02-18 | 2021-02-22 | 2,096 | $9.57 | $20.1K | 15,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-02-18 | 2021-02-22 | 2,647 | $34.19 | $90.5K | 12,353 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-02-18 | 2021-02-22 | 4,553 | $35.02 | $159.4K | 7,800 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-02-18 | 2021-02-22 | 6,400 | $35.99 | $230.3K | 1,400 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-02-18 | 2021-02-22 | 1,000 | $36.92 | $36.9K | 400 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | S Sale | 2021-02-18 | 2021-02-22 | 400 | $37.88 | $15.2K | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-12 | 40,000 | — | $0 | 40,000 | SEC↗ |